A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur–uracil versus surgery alone in stage II colon cancer: SACURA trial

Author:

Matsuda Chu,Ishiguro MegumiORCID,Teramukai Satoshi,Kajiwara Yoshiki,Fujii Shoichi,Kinugasa Yusuke,Nakamoto YoshihikoORCID,Kotake Masanori,Sakamoto Yoshiyuki,Kurachi Kiyotaka,Maeda Atsuyuki,Komori Koji,Tomita Naohiro,Shimada Yasuhiro,Takahashi Keiichi,Kotake Kenjiro,Watanabe Masahiko,Mochizuki Hidetaka,Nakagawa Yoko,Sugihara Kenichi

Funder

Foundation for Biomedical Research and Innovation

Taiho Pharmaceutical Co. Ltd., Japan

Taiho Pharmaceutical Co. Ltd

Chugai Pharmaceutical Co. Ltd.

Yakult Honsha Co. Ltd

Taiho

Chugai

Yakult

Eli Lilly Japan

Merck Serono Co. Ltd.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference18 articles.

1. Center for Cancer Control and Information Services, National Cancer Center. Projected cancer statistics, 2017. http://ganjoho.jp/en/public/statistics/short_pred.html; 2017 [Accessed 5 December 2017].

2. Adjuvant chemotherapy for stage II colon cancer: a clinical dilemma;Kannarkatt;J Oncol Pract,2017

3. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04);Mamounas;J Clin Oncol,1999

4. Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials;Sakamoto;J Clin Oncol,2004

5. Adjuvant chemotherapy use for medicare beneficiaries with stage II colon cancer;Schrag;J Clin Oncol,2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3